Resistant Microbial Keratitis in South Nile Delta, Egypt: Influence of Regional Risk Factors.
OBJECTIVE
This study was conducted in an attempt to identify the regional, geographic, climatic, socioeconomic, and other risk factors for microbial keratitis in south Nile Delta, Egypt.


METHODS
This is a prospective cross-sectional study that was carried out on 340 eyes of 340 patients with microbial keratitis attending at the outpatient clinic of Ophthalmology Department of Menoufia University Hospital during a period of three years between March 2010 and March 2013.


RESULTS
Epidemiological factors, lines of management, and follow-up results were recorded and statistically analyzed and there were regional variations in the prevalence, risk factors, and outcome in resistant corneal ulcers.


CONCLUSIONS
Higher incidence of affections and complications has appeared in farmers, rural area residents, and illiterates which are considered the main predisposing factors for ulcer resistance. According to culture results, bacterial organisms (especially Staphylococcus aureus) were the main cause of resistant corneal ulcers.
a Department of Ophthalmology, Menoufia Faculty of Medicine , Shebin El Kom , Menoufia , Egypt.
Sameh S
SS
Mandour
a Department of Ophthalmology, Menoufia Faculty of Medicine , Shebin El Kom , Menoufia , Egypt.
Hatem M
HM
Marey
a Department of Ophthalmology, Menoufia Faculty of Medicine , Shebin El Kom , Menoufia , Egypt.
Hassan G
HG
Farahat
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D002980:Climate; D003320:Corneal Ulcer / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D003430:Cross-Sectional Studies; D024881:Drug Resistance, Bacterial; D025141:Drug Resistance, Fungal; D004359:Drug Therapy, Combination; D004534:Egypt / Q000453:epidemiology; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D015821:Eye Infections, Fungal / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D005260:Female; D024841:Fluoroquinolones / Q000627:therapeutic use; D005658:Fungi / Q000302:isolation & purification; D005843:Geography; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D010866:Natamycin / Q000627:therapeutic use; D011446:Prospective Studies; D012307:Risk Factors; D012923:Social Class
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D010866:Natamycin; D007654:Ketoconazole; D000077266:Moxifloxacin
Cornea; Egypt; Nile Delta; microbial ulcer; resistant keratitis